11th Jul 2016 08:52
LONDON (Alliance News) - Deltex Medical Group PLC announced on Monday results from the first randomised controlled trial comparing post-operative outcomes using Oesophageal Doppler monitoring compared to the most commonly used alternative, Pulse Pressure Waveform Analysis.
ODM is manufactured by Deltex and is the only technology to continuously measure blood flow in the central circulation, to help guide fluid and drug administration accurately following surgery, the company said. In a test comparing 127 patients recovering from bowel surgery, half the patients care was guided using ODM and the other half using PPWA.
The results were positive for ODM. The PPWA device gave patients too little or too much fluid two times out of every five, and 50% more PPWA patients required treatment with vaso-active drugs. ODM patients were able to get out of bed and move around on average one day sooner and went home on average two days earlier.
Prior to these results, there have been 13 studies using ODM with positive outcomes and eight trials using this particular PPWA device with no positive outcomes.
"These results confirm both the superiority of ODM over PPWA and that intra-operative fluid management, done properly, has a crucial role in determining optimal patient outcomes in modern enhanced recovery programmes incuding laparoscopic surgical techniques," Said Ewan Phillips, chief executive of Deltex Medical.
Shares in Deltex were up 4.1% Monday morning at 4.95 pence.
By Lucy Heming; [email protected]
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
Deltex Medical